Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017 2018 2019

Details for Mechanism ID: 13601
Country/Region: Namibia
Year: 2016
Main Partner: Society for Family Health
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $0 Additional Pipeline Funding: $1,600,000

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Testing: HIV Testing and Counseling (HVCT) $0
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Treatment: Adult Treatment (HTXS) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 26
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 21
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 3,775
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 2,182
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 6,669
HTS_TST Service Delivery Point (Community): Other 2017 5,546
HTS_TST Service Delivery Point (Facility): VCT 2017 723
HTS_TST Sum of Aggregated Age/Sex <15 2017 47
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 5,957
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 6,004
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 3
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 2
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 430
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 232
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 8,000
KP_PREV By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 550
KP_PREV By key population type: Men who have sex with men who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 250
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2017 8,800
KP_PREV Total estimated number of key population in the catchment area 2017 176,000
KP_PREV_den By key population type: Female sex workers (FSW) (Denominator: Total estimated number of key population in the catchment area) 2017 160,000
KP_PREV_den By key population type: Men who have sex with men who are NOT sex workers (Denominator: Total estimated number of key population in the catchment area) 2017 11,000
KP_PREV_den By key population type: Men who have sex with men who are sex workers (Denominator: Total estimated number of key population in the catchment area 2017 5,000
TX_CURR Aggregated Age/Sex: 15+ Female 2017 255
TX_CURR Aggregated Age/Sex: 15+ Male 2017 45
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 300
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 300
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 300
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 255
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 45
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 300
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 300
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 210
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 178
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 32
TX_PVLS Numerator: Indication: Routine 2017 105
TX_PVLS Numerator: Indication: Targeted 2017 105
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 222
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 32
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 264
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 300
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 255
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 45